By
Latest Stories
Don’t miss our hot and upcoming stories
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic Collaborations to Advance Therapies for Fibrotic Diseases and Osteoarthritis
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery,…
Recursion Reports Promising Interim Data for AI-Designed CDK7 Inhibitor in Ovarian Cancer
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug…
Recursion Doses First Patient in Phase 1/2 Trial of REC-1245 for Biomarker-Enriched Solid Tumors and Lymphoma
Recursion (NASDAQ: RXRX), a cutting-edge clinical-stage TechBio company, has announced the successful dosing of the…
AI Drug Discovery Leaders Recursion and Exscientia Merge to Transform Drug Discovery
Recursion and Exscientia, two trailblazers in AI-driven drug discovery, have officially merged to form a…